Skip to content
★ Sign in to follow
DC

Denis Corin

Executive
Chief Executive Officer
Q BioMed Inc.Marker Therapeutics, Inc.
Total declarations
20
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€194k

Latest filing published 31 May 2022 for Q BioMed Inc., €3.7B.

Filing timeline

BuySale
Denis Corin

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

Denis Corin: trading record in brief

Denis Corin, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Q BioMed Inc. and Marker Therapeutics, Inc. Over a trading history stretching from 29 June 2009 to 26 May 2022, the count stands at 20 filings.

No open-market purchase appears, only 15 sales worth €194k. Outside the open market, there are 1 share grant.

On 31 May 2022 came the latest disclosure, a share grant for €3.7B in Q BioMed Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Denis Corin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ◆
    Chief Executive OfficerExecutivesQ BioMed Inc.
    4B USD30SEC
    200,000 shares@ US$20,000.00100.0% of flowCommon StockSEC:0001104659-22-066485:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    13,504 USD0SEC
    6,400 shares@ US$2.11Common StockSEC:0001405626-19-000001:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    23,590 USD23SEC
    7,000 shares@ US$3.3711.9% of flowCommon StockSEC:0001405626-18-000008:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    19,950 USD23SEC
    7,000 shares@ US$2.8510.1% of flowCommon StockSEC:0001405626-18-000008:1
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    23,364 USD23SEC
    6,600 shares@ US$3.5411.8% of flowCommon StockSEC:0001405626-18-000007:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    24,702 USD23SEC
    6,900 shares@ US$3.5812.5% of flowCommon StockSEC:0001405626-18-000007:1
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    6,840 USD22SEC
    2,000 shares@ US$3.423.5% of flowCommon StockSEC:0001405626-18-000006:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    7,612 USD22SEC
    2,200 shares@ US$3.463.9% of flowCommon StockSEC:0001405626-18-000006:1
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    17,967 USD23SEC
    5,300 shares@ US$3.399.2% of flowCommon StockSEC:0001405626-18-000005:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    7,140 USD22SEC
    2,100 shares@ US$3.403.7% of flowCommon StockSEC:0001405626-18-000005:1
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    13,034 USD23SEC
    3,800 shares@ US$3.436.6% of flowCommon StockSEC:0001405626-18-000004:1
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    16,856 USD23SEC
    4,900 shares@ US$3.448.6% of flowCommon StockSEC:0001405626-18-000004:2
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    4,788 USD22SEC
    1,400 shares@ US$3.422.4% of flowCommon StockSEC:0001405626-18-000004:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    19,779 USD23SEC
    5,700 shares@ US$3.4710.1% of flowCommon StockSEC:0001405626-18-000003:0
  • ▼
    Chief Executive OfficerExecutivesQ BioMed Inc.
    11,385 USD23SEC
    3,300 shares@ US$3.455.8% of flowCommon StockSEC:0001405626-18-000003:1
  • ●
    PresidentExecutivesMarker Therapeutics, Inc.
    25,000 USD0SEC
    166,667 shares@ US$0.15Common StockSEC:0001140361-12-021069:0
  • ●
    President and CFOExecutivesMarker Therapeutics, Inc.
    50,000 USD0SEC
    294,118 shares@ US$0.17Common StockSEC:0001144204-11-020269:0
  • ▼
    President and CFOExecutivesMarker Therapeutics, Inc.
    19,200 USD0SEC
    160,000 shares@ US$0.12Common StockSEC:0001144204-11-020269:1
  • ●
    PresidentExecutivesMarker Therapeutics, Inc.
    192,575 USD0SEC
    1,925,750 shares@ US$0.10Common stockSEC:0001183740-09-000485:0
  • ●
    PresidentExecutivesMarker Therapeutics, Inc.
    29,530 USD0SEC
    295,300 shares@ US$0.10Common stockSEC:0001183740-09-000485:1

20 of 20 declarations